Hydrogen peroxide and antioxidizing enzymes involved in modulation of transient facilitatory effects of nicotine on neurogenic contractile responses in rat gastric fundus.
Nicotine acts as an agonist of nicotinic acetylcholine receptors. Nicotinic acetylcholine receptors play a role in the modulation of neurotransmitter release in both the central and the peripheral nervous system. Moderate reactive oxygen species levels modulate the regulation of physiological functions e.g. neurotransmitter release. Previously in rabbit gastric fundus we demonstrated that nicotine transiently increased neurogenic contraction induced by electrical field stimulation (EFS). In this study we aimed to investigate the effects of hydrogen peroxide (H2O2), antioxidizing enzymes catalase and superoxide dismutase (SOD) on nicotine induced increases at cholinergic neurotransmission in rabbit gastric fundus. Although H2O2 did not alter nicotine induced transient neurogenic contractions at concentrations of 10(-6) and 10(-5) M, at high concentration (10(-4) M) H2O2 inhibited nicotine induced increases. Catalase (500 units/ml), enhanced the effect of nicotine but did not alter nicotine induced transient neurogenic contractions at the concentrations of 100 and 250 units/ml. SOD (75,150 and 225 units/ml) did not alter nicotine induced transient neurogenic contractions. In conclusion, at high concentration H2O2 (10(-4) M) inhibited nicotine's transient ability to augment neurogenic contractions and catalase (500 units/ml) enhanced the effect of nicotine.
Ozger Ilhan
Sevil
S
Department of Pharmacology, Medical School, UfukUniversity, Ankara, Turkey.
Sarioglu
Yusuf
Y
Vural
Ismail Mert
IM
Dileköz
Ergin
E
Oztürk
Gökçe Sevim
GS
Ercan
Zeynep Sevim
ZS
D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D001285:Atropine / Q000494:pharmacology; D002374:Catalase / Q000494:pharmacology*; D004558:Electric Stimulation; D005748:Gastric Fundus / Q000187:drug effects / Q000294:innervation; D006861:Hydrogen Peroxide / Q000494:pharmacology*; D066298:In Vitro Techniques; D018727:Muscarinic Antagonists / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects* / Q000294:innervation*; D009538:Nicotine / Q000494:pharmacology*; D018722:Nicotinic Agonists / Q000494:pharmacology*; D010275:Parasympathetic Nervous System / Q000187:drug effects; D011817:Rabbits; D026941:Sodium Channel Blockers / Q000494:pharmacology; D013482:Superoxide Dismutase / Q000494:pharmacology*; D009435:Synaptic Transmission / Q000187:drug effects
D000975:Antioxidants; D018727:Muscarinic Antagonists; D018722:Nicotinic Agonists; D026941:Sodium Channel Blockers; D009538:Nicotine; D001285:Atropine; D006861:Hydrogen Peroxide; D002374:Catalase; D013482:Superoxide Dismutase